Skip to main content
SpringerLink
Log in

Procalcitonin on the Dusty Way to the Holy Grail: A Progress Report

  • Conference paper
Yearbook of Intensive Care and Emergency Medicine 2005

Part of the book series: EN]Yearbook of Intensive Care and Emergency Medicine ((volume 2005))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr (2004) Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512–1525

    Article  PubMed  Google Scholar 

  2. Weglohner W, Struck J, Fischer-Schulz C, et al (2001) Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides 22:2099–2103

    Article  PubMed  Google Scholar 

  3. Copp DH, Davidson AGP (1961) Evidence for a new parathyroid hormone which lowers blood calcium. Proc Soc Biol Med 107:342–344

    Google Scholar 

  4. Becker KL, Muller B, Nylen ES, Cohen R, Silva OL, Snider RH (2001) Calcitonin gene family of peptides. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. Vol. 3rd edition. J.B. Lippincott Co, Philadeplphia, pp 520–534

    Google Scholar 

  5. Zaidi M, Moonga BS, Abe E (2002) Calcitonin and bone formation: a knockout full of surprises. J Clin Invest 110:1769–1771

    Article  PubMed  Google Scholar 

  6. Hoff AO, Catala-Lehnen P, Thomas PM, et al (2002) Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest 110:1849–1857

    Article  PubMed  Google Scholar 

  7. Hirsch PF, Baruch H (2003) Is calcitonin an important physiological substance? Endocrine 21:201–208

    Article  PubMed  Google Scholar 

  8. Nylen ES, O'Neill W, Jordan MH, et al (1992) Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 24:439–443

    PubMed  Google Scholar 

  9. Whang KT, Steinwald PM, White JC, et al (1998) Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 83:3296–3301

    PubMed  Google Scholar 

  10. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518

    Article  PubMed  Google Scholar 

  11. Muller B, Becker KL, Schächinger H, et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983

    Article  PubMed  Google Scholar 

  12. de Werra I, Jaccard C, Corradin SB, et al (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613

    Article  PubMed  Google Scholar 

  13. Simon L, Gauvin F, Anre K, Saint-Louis P, Lacroix J (2004) Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clin Infect Dis 39:206–217

    Article  PubMed  Google Scholar 

  14. Snider RH Jr, Nylen ES, Becker KL (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45:552–560

    PubMed  Google Scholar 

  15. Nylen ES, Muller B, Becker KL, Snyder RH (2003) The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 36:823–824

    Article  PubMed  Google Scholar 

  16. Christ-Crain M, Jaccard-Stols D, Bingisser R, et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600–607

    Article  PubMed  Google Scholar 

  17. Albrich W, Monnet D, Harbarth S (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 10:514–517

    PubMed  Google Scholar 

  18. Snider RH Jr, Nylen ES, Becker KL (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45:552–560

    PubMed  Google Scholar 

  19. Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323:17–29

    PubMed  Google Scholar 

  20. Meisner M, Brunkhorst FM, Reith HB, Schmidt J, Lestin HG, Reinhart K (2000) Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 38:989–995

    Article  PubMed  Google Scholar 

  21. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH (1993) Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 341:511–514

    Article  PubMed  Google Scholar 

  22. Ortqvist A (1995) Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemother 35:205–212

    PubMed  Google Scholar 

  23. Halls GA (1993) The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 31:985–1000

    PubMed  Google Scholar 

  24. Stephenson J (1996) Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA 275:175

    Article  PubMed  Google Scholar 

  25. Wenzel RP, Wong MT (1999) Managing antibiotic use-impact of infection control. Clin Infect Dis 28:1126–1127

    PubMed  Google Scholar 

  26. Chen DK, McGeer A, de Azavedo JC, Low DE (1999) Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 343:233–239

    Article  Google Scholar 

  27. Gonzales R, Steiner JF, Lum A, Barrett PH Jr (1999) Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 281:1512–1519

    Article  PubMed  Google Scholar 

  28. Guillemot D, Courvalin P (2001) Better control of antibiotic resistance. Clin Infect Dis 33:542–547

    Article  PubMed  Google Scholar 

  29. Ball P, Baquero F, Cars O, et al (2002) Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 49:31–40

    Article  Google Scholar 

  30. Halm EA, Teirstein AS (2002) Clinical practice. Management of community-acquired pneumonia. N Engl J Med 347:2039–2045

    Article  PubMed  Google Scholar 

  31. Gonzales R, Sande MA (2000) Uncomplicated acute bronchitis. Ann Intern Med 133:981–991

    PubMed  Google Scholar 

  32. Sethi S, Murphy TF (2001) Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 14:336–363

    Article  PubMed  Google Scholar 

  33. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196–204

    PubMed  Google Scholar 

  34. Muller B, Becker KL, Schachinger H, et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983

    Article  PubMed  Google Scholar 

  35. Bernard GR, Vincent JL, Laterre PF, et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  PubMed  Google Scholar 

  36. Marik PE (2000) The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators. J Crit Care 15:85–90

    Article  PubMed  Google Scholar 

  37. Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y (2002) Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 359:1648–1654

    Article  PubMed  Google Scholar 

  38. Muller B, Becker KL, Becker KL, et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983

    Article  PubMed  Google Scholar 

  39. Nylen ES, Snider RH Jr, Thompson KA, Rohatgi P, Becker KL (1996) Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 312:12–18

    Article  PubMed  Google Scholar 

  40. Muller B, Becker KL (2001) Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 131:595–602

    PubMed  Google Scholar 

  41. Gonzales R (2003) A 65-year-old woman with acute cough illness and an important engagement. JAMA 289:2701–2708

    PubMed  Google Scholar 

  42. Hament JM, Kimpen JL, Fleer A, Wolfs TF (1999) Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 26:189–195

    Article  PubMed  Google Scholar 

  43. Sethi S, Evans N, Grant BJ, Murphy TF (2002) New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347:465–471

    Article  PubMed  Google Scholar 

  44. Strausbaugh LJ, Sukumar SR, Joseph CL (2003) Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 36:870–876

    Article  PubMed  Google Scholar 

  45. Steinwald PM, Whang KT, Becker KL, Snider RH, Nylen ES, White JC (1999) Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care 3:11–16

    Article  PubMed  Google Scholar 

  46. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26:1001–1006

    Article  PubMed  Google Scholar 

  47. Whang KT, Vath SD, Becker KL, et al (2000) Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 14:73–78

    PubMed  Google Scholar 

  48. Wagner KE, Vath SD, Snider RH, et al (2002) Immunoneutralization of elevated calcitonin precursors markedly attenuates the adverse response to sepsis in pigs. Crit Care Med 30:2313–2321

    Article  PubMed  Google Scholar 

  49. Martinez JM, Becker KL, Muller B, et al (2001) Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surgical Inf 2:193–201

    Article  Google Scholar 

  50. Hoffmann G, Czechowski M, Schloesser M, Schobersberger W (2002) Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 30:2091–2095

    Article  PubMed  Google Scholar 

  51. Muller B, Becker KL, Kränzlin M, et al (2000) Disordered calcium homeostasis of sepsis: associated with calcitonin precursors. Eur J Clin Invest 30:823–831

    Article  PubMed  Google Scholar 

  52. Preas HL, 2nd, Nylen ES, Snider RH, et al (2001) Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 184:373–376

    Article  PubMed  Google Scholar 

  53. Linscheid P, Seboek D, Nylen ES, et al (2003) In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144:5578–5584

    Article  PubMed  Google Scholar 

  54. Muller B, White JC, Nylen E, Snider RH, Becker KL, Habener JF (2001) Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396–404

    Article  PubMed  Google Scholar 

  55. Monneret G, Laroche B, Bienvenu J (1999) Procalcitonin is not produced by circulating blood cells. Infection 27:34–35

    PubMed  Google Scholar 

  56. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715–1721

    Article  PubMed  Google Scholar 

  57. Suarez Domenech V, White JC, Nylen ES, et al (2001) Calcitonin gene-related peptide: messenger RNA in bacterial sepsis: Postulation of microbial infection-specific response elements (MISRE) within the Calc-I gene promoter. J Invest Med 49:514–521

    Google Scholar 

  58. McLatchie LM, Fraser NJ, Main MJ, et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339

    Article  PubMed  Google Scholar 

  59. Harbarth S, Holeckova K, Froidevaux C, et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396–402

    PubMed  Google Scholar 

  60. Mueller C, Huber R, Laifer G, Mueller B, Buerkle G, Perruchoud AP (2004) Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109:1707–1710

    Article  PubMed  Google Scholar 

  61. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG (1997) The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832–840

    PubMed  Google Scholar 

  62. Kylanpaa-Back ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, Repo H (2001) Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 88:222–227

    Article  PubMed  Google Scholar 

  63. Ammori BJ, Becker KL, Kite P, et al (2003) Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 27:239–243

    Article  PubMed  Google Scholar 

  64. Ammori BJ, Becker KL, Kite P, et al (2003) Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission. Br J Surg 90:197–204

    Article  PubMed  Google Scholar 

  65. Muller B, Becker KL (2001) Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 131:595–602

    PubMed  Google Scholar 

  66. Bihari D (2004) Monitoring procalcitonin is of value in acute pancreatitis. BMJ 329:232

    Article  Google Scholar 

  67. Marc E, Menager C, Moulin F, et al (2002) [Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak]. Arch Pediatr 9:358–364

    Article  PubMed  Google Scholar 

  68. Becker KL, Nylen ES, Snider RH, Muller B, White JC (2003) Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res 9:367–374

    Article  PubMed  Google Scholar 

Download references

Authors
  1. M. Christ-Crain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Christ-Crain, M., Müller, B. (2005). Procalcitonin on the Dusty Way to the Holy Grail: A Progress Report. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_40

Download citation

  • DOI: https://doi.org/10.1007/0-387-26272-5_40

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-23476-0

  • Online ISBN: 978-0-387-26272-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation